The Pharmacological Mechanism of Xiyanping Injection for the Treatment of Novel Coronavirus Pneumonia (COVID-19): Based on Network Pharmacology Strategy.

Liang-Jing XiaLiang-Ming ZhangKun Yang Tong Chen Xian-Wen Ye Zi-Jun Yan

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

Xiyanping injection may inhibit the release of various inflammatory factors by inhibiting intracellular pathways such as MAPK and TNF. It acts on protein targets such as HSP90AA1 and plays a potential therapeutic role in COVID-19. Thus, compound III may be treated as a potential new drug for the treatment of COVID-19 and the Xiyanping injection may treat patients with COVID-19 infection.

Keyphrases

coronavirus disease
sars cov
signaling pathway
oxidative stress
ultrasound guided
rheumatoid arthritis
cell proliferation
respiratory syndrome coronavirus
small molecule
climate change
reactive oxygen species
heat shock
adverse drug